Overview

VNA and PACS Market is estimated to value over USD 641.58 million by 2027 end with a CAGR of over 15% during the forecast period 2020 to 2027.

Healthcare organizations are innovating in creating affordable care services and meeting the needs of value-based payments. VNA and PACS enable the healthcare systems for efficient management of medical images, streamlining business and clinical workflows. These methods shall help healthcare providers in improving the treatment quality, reducing costs, increasing efficiency and shifting resources for innovation. Furthermore, increased grants and investments by companies and government bodies in medical imaging plays a crucial role in implementing these imaging technologies, improving a patient’s quality of life, modernizing imaging facilities. For example, the European Investment Bank in November 2017 announced that they will provide a financial assistance of over EUR 25 million to a Berlin-based company, Medneo Group, offering novel imaging diagnostics technology and services. Such investments in the field of medical imaging is primarily responsible for the VNA and PACS market growth.
There has been a surge in the usage of AI in medical imaging. Major market players are developing in-house AI solutions to promote them as integrated or supplementary offerings with their marquee HCIT products. Since 2015, over 40 start-ups developing machine learning and AI-based medical imaging solutions have entered the market. Such a booming demand for AI has aided in the proliferation of the market. 

Major players included in the VNA and PACS Market:
• Acuo Technologies
• Agfa Healthcare
• Bridgehead Software
• GE Healthcare
• Dejarnette Research Systems, Inc.
• Dell, Inc.
• McKesson Corporation
• Carestream Health
• Fujifilm Corporation
• Siemens Healthineers
• Merge Healthcare Inc.(IBM)
• Mach 7 Technologies
• Novarad Corporation
• Philips Healthcare
• Teramedica
(Note: The list of the major players will be updated with the latest market scenario and trends)

Market Segmentation:

By Procurement Model
• Departmental VNA
• Multi-Departmental VNA
• Multi-Site VNA

By Player Type
• PACS Vendors
• Independent Software Vendors
• Infrastructure Vendors

By Delivery Mode
• On-Premise (On-Site) VNA
• Hybrid VNA
• Fully Cloud-Hosted VNA

By Region
•    North America
•    Europe
•    Asia-Pacific
•    Latin America
•    Middle East and Africa

The market is classified into procurement, delivery mode, end user and region. The department segment is fragmented into cardiology, radiology, pathology, ortho and oncology. The departmental PACS segment is predicted to hold the largest VNA and PACS market share and this can be credited to an rising pressure of improving the care quality, increasing efforts for enhancing the patient experience keeping the cost as low as possible, a wide range of imaging applications in radiology, escalating rise in storing, indexing, sharing and capturing medical images. The delivery mode is categorised into hybrid VNA, fully cloud based VNAs and on-premise VNAs. The on-premise VNAs lead the market revenue-wise owing to an increasing preference for this mode over others. This is due to high security and better data control offered by on-premise VNA solutions. However, the hybrid VNAs are predicted to grow at a significant rate during the forecast period. 

Regional Analysis:

The North America region dominated the market and it is predicted to continue its domination throughout the forecast period. This is mainly due to programs like Healthcare Insurance Portability and Accountability, advancements in medical imaging technologies and rising adoption of PACS and VNAs in hospitals and other healthcare settings.

Competitive Landscape:

• Tier 1 players- established companies in the market with a major market share
• Tier 2 players
• Emerging players which are growing rapidly
• New Entrants                           

FutureWise Key Takeaways:

•    Growth prospects
•    SWOT analysis 
•    Key market trends 
•    Key data-points affecting market growth

Objectives of the Study:

•    To provide with an exhaustive analysis on the global VNA and PACS market By Procurement Model, By Player Type, By Delivery Mode and by region
•    To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
•    To evaluate and forecast micro-markets and the overall market 
•    To predict the market size, in key regions (along with countries)— North America, Europe, Asia Pacific, Latin America and Middle East and Africa
•    To record, evaluate and analyze competitive landscape mapping- product launches, technological advancements, mergers and expansions     

Flexible Delivery Model:

•    We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
•    The customization Mobility Care offered are free of charge with purchase of any license of the report
•    You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

Table of Contents

1. Market Introduction
   1.1. Objectives of the Study 
   1.2. Market Definition 
   1.3. Market Scope 
        1.3.1. Years Considered for the Study
        1.3.2. Market Covered
   1.4. Currency 
   1.5. Limitations 
   1.6. Stakeholders 

2. Research Methodology 
   2.1. Research Data 
        2.1.1. Secondary Data
               2.1.1.1. Key Data from Secondary Sources
        2.1.2. Primary Data
               2.1.2.1. Key Data from Primary Sources
   2.2. Market Size Estimation 
   2.3. Market Breakdown and Data Triangulation 
   2.4. Assumptions for the Study  

3. Executive Summary
   3.1. Market Outlook
   3.2. Segment Outlook
   3.3. Competitive Insights

4. Global VNA and PACS Market Variables, Trends & Scope
   4.1. Market Lineage Outlook
   4.2. Penetration and Growth Prospect Mapping
   4.3. Industry Value Chain Analysis
   4.4. Cost Analysis Breakdown
   4.5. Technology Overview
   4.6. Regulatory Framework
        4.6.1. Reimbursement Framework
        4.6.2. Standards and Compliances

5. Market Overview
   5.1. Market Dynamics
        5.1.1. Market Driver Analysis
               5.1.1.1. Increasing focus of VNA and PACS Companies on Brand Protection
               5.1.1.2. Untapped Opportunities in Emerging Regions
        5.1.2. Market Restraint Analysis
               5.1.2.1. High Cost Associated with Implementation of Predictive Analysis
        5.1.3. Industry Challenges
               5.1.3.1. Presence of Ambiguous Regulatory Framework

6. VNA and PACS Market Analysis Tools
   6.1. Industry Analysis - Porter’s
        6.1.1. Supplier Power
        6.1.2. Buyer Power
        6.1.3. Substitution Threat
        6.1.4. Threat from New Entrants
        6.1.5. Competitive Rivalry
   6.2. Pestel Analysis
        6.2.1. Political Landscape
        6.2.2. Environmental Landscape
        6.2.3. Social Landscape
        6.2.4. Technology Landscape
        6.2.5. Legal Landscape
   6.3. Major Deals And Strategic Alliances Analysis
        6.3.1. Joint Ventures
        6.3.2. Mergers and Acquisitions
        6.3.3. Licensing and Partnership
        6.3.4. Technology Collaborations
        6.3.5. Strategic Divestments
   6.4. Market Entry Strategies
   6.5. Case Studies

7. VNA and PACS Market, By Procurement Model Historical Analysis and Forecast 2020-2027 (USD Million)
   7.1. Departmental VNA
   7.2. Multi-Departmental VNA
   7.3. Multi-Site VNA

8. Global VNA and PACS Market, By Player Type Historical Analysis and Forecast 2020-2027 (USD Million)  
   8.1. PACS Vendors   
   8.2. Independent Software Vendors
   8.3. Infrastructure Vendors

9. Global VNA and PACS Market, By Delivery Mode Historical Analysis and Forecast 2020-2027 (USD Million)  
   9.1. On-Premise (On-Site) VNA
   9.2. Hybrid VNA
   9.3. Fully Cloud-Hosted VNA

10. North America VNA and PACS Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million)
    10.1. Introduction
    10.2. Historical Market Size (USD Million) Analysis By Country, 2015-2019
          10.2.1. U.S.A
          10.2.2. Canada
          10.2.3. Mexico
    10.3. Market Size (USD Million) Forecast for North America 2020-2027

11. Latin America VNA and PACS Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million)
    11.1. Introduction
    11.2. Historical Market Size (USD Million) Analysis By Country, 2015-2019
          11.2.1. Brazil
          11.2.2. Venezuela
          11.2.3. Argentina
          11.2.4. Rest of Latin America
    11.3. Market Size (USD Million) Forecast for Latin America 2020-2027

12. Europe VNA and PACS Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million)
    12.1. Introduction
    12.2. Historical Market Size (USD Million) Analysis By Country, 2015-2019
          12.2.1. Germany
          12.2.2. U.K         
          12.2.3. France
          12.2.4. Italy
          12.2.5. Spain
          12.2.6. Russia
          12.2.7. Poland
          12.2.8. Rest of Europe
    12.3. Market Size (USD Million) Forecast for Europe 2020-2027

13. Asia Pacific VNA and PACS Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million)
    13.1. Introduction
    13.2. Historical Market Size (USD Million) Analysis By Country, 2015-2019
          13.2.1. Japan
          13.2.2. China
          13.2.3. India
          13.2.4. Australia and New Zealand
          13.2.5. ASEAN
          13.2.6. Rest of Asia Pacific
    13.3. Market Size (USD Million) Forecast for Asia Pacific 2020-2027  

14. Middle East and Africa Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million)
    14.1. Introduction
    14.2. Historical Market Size (USD Million) Analysis By Country, 2015-2019
          14.2.1. Saudi Arabia
          14.2.2. UAE
          14.2.3. South Africa
          14.2.4. Egypt
    14.3. Market Size (USD Million) Forecast for MEA 2020-2027

15. Market Share Analysis and Competitive Landscape   
    15.1. Global Landscape - Key Players, Revenue and Presence
    15.2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
    15.3. Global Emerging Companies
    15.4. North America - Market Share Analysis and Key Regional Players
    15.5. Europe - Market Share Analysis and Key Regional Players
    15.6. Asia Pacific - Market Share Analysis and Key Regional Players
    15.7. Global Key Player - Growth Matrix

16. Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts)
    16.1. Acuo Technologies
          16.1.1. Company Overview
          16.1.2. Product Portfolio
          16.1.3. SWOT Analysis
          16.1.4. Financial Overview
          16.1.5. Strategic Overview
    16.2. Agfa Healthcare
          16.2.1. Company Overview
          16.2.2. Product Portfolio
          16.2.3. SWOT Analysis
          16.2.4. Financial Overview
          16.2.5. Strategic Overview 
    16.3. Bridgehead Software
          16.3.1. Company Overview
          16.3.2. Product Portfolio
          16.3.3. SWOT Analysis
          16.3.4. Financial Overview
          16.3.5. Strategic Overview
    16.4. GE Healthcare
          16.4.1. Company Overview
          16.4.2. Product Portfolio
          16.4.3. SWOT Analysis
          16.4.4. Financial Overview
          16.4.5. Strategic Overview
    16.5.  Dejarnette Research Systems, Inc.
          16.5.1. Company Overview
          16.5.2. Product Portfolio
          16.5.3. SWOT Analysis
          16.5.4. Financial Overview
          16.5.5. Strategic Overview          
    16.6.  Dell, Inc.
          16.6.1. Company Overview
          16.6.2. Product Portfolio
          16.6.3. SWOT Analysis
          16.6.4. Financial Overview
          16.6.5. Strategic Overview      
    16.7. McKesson Corporation
          16.7.1. Company Overview
          16.7.2. Product Portfolio
          16.7.3. SWOT Analysis
          16.7.4. Financial Overview
          16.7.5. Strategic Overview
    16.8. Carestream Health
          16.8.1. Company Overview
          16.8.2. Product Portfolio
          16.8.3. SWOT Analysis
          16.8.4. Financial Overview
          16.8.5. Strategic Overview 
    16.9. Fujifilm Corporation
          16.9.1. Company Overview
          16.9.2. Product Portfolio
          16.9.3. SWOT Analysis
          16.9.4. Financial Overview
          16.9.5. Strategic Overview 
    16.10. Siemens Healthineers
          16.10.1. Company Overview
          16.10.2. Product Portfolio
          16.10.3. SWOT Analysis
          16.10.4. Financial Overview
          16.10.5. Strategic Overview 
    16.11. Merge Healthcare Inc. (IBM)
          16.11.1. Company Overview
          16.11.2. Product Portfolio
          16.11.3. SWOT Analysis
          16.11.4. Financial Overview
          16.11.5. Strategic Overview      
    16.12. Mach 7 Technologies
          16.12.1. Company Overview
          16.12.2. Product Portfolio
          16.12.3. SWOT Analysis
          16.12.4. Financial Overview
          16.12.5. Strategic Overview 
    16.13. Novarad Corporation
          16.13.1. Company Overview
          16.13.2. Product Portfolio
          16.13.3. SWOT Analysis
          16.13.4. Financial Overview
          16.13.5. Strategic Overview
    16.14. Philips Healthcare
          16.14.1. Company Overview
          16.14.2. Product Portfolio
          16.14.3. SWOT Analysis
          16.14.4. Financial Overview
          16.14.5. Strategic Overview
    16.15. Teramedica
          16.15.1. Company Overview
          16.15.2. Product Portfolio
          16.15.3. SWOT Analysis
          16.15.4. Financial Overview
          16.15.5. Strategic Overview    
  
17. Pre and Post COVID-19 Impact
    17.1. Positive influence on the healthcare industry
    17.2. The financial disruption of the manufacturing sector
    17.3. Impact of COVID-19 on emerging companies
    17.4. Significant mandates in the healthcare regulations initiated by administrations
    17.5. The overall economic slowdown of the developing and developed nations

18. FutureWise SME Key Takeaway Points for Client
 

Tables

Figures